The Massachusetts Biotechnology Council (MBC) has announced an alliance with Fisher Scientific, part of Thermo Fisher Scientific. As a primary supplier, Fisher Scientific will support the product and supply chain service needs of Massachusetts biotechnology companies and will help to accelerate the industry's growth.
The Massachusetts Biotechnology Council (MBC) has announced an alliance with Fisher Scientific, part of Thermo Fisher Scientific. As a primary supplier, Fisher Scientific will support the product and supply chain service needs of Massachusetts biotechnology companies and will help to accelerate the industry's growth. This solutions-based alliance will give MBC member companies access to the array of technologies offered by Fisher Scientific including scientific, safety and laboratory products.
"We believe that Fisher Scientifics' portfolio of technologies, lab supply products and services will provide the quality and savings we demand for our members," said Robert K. Coughlin, MBC president and CEO. "This partnership will help us fulfil our mission of fostering an environment that enables every biotechnology company to reach its full potential."
Further information about Fisher Scientific is available on-line at www.fishersci.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.